ASPADOL 75 ATB is a prescription-strength pharmaceutical tablet formulated with 75 mg of Tapentadol Hydrochloride, designed specifically for the effective management of moderate to severe acute and chronic pain conditions. This advanced analgesic combines dual mechanisms—mu-opioid receptor agonism and norepinephrine reuptake inhibition—to deliver rapid onset and sustained pain relief. It offers a superior safety profile compared to traditional opioids, significantly reducing common gastrointestinal side effects such as nausea, vomiting, and constipation, which enhances patient tolerance and adherence during therapy. The 75 mg dosage of ASPADOL 75 ATB is ideal for patients requiring a mid-level potency analgesic, often used as an intermediary step during pain management dose titration or where moderate escalated pain relief is warranted. Its formulation ensures fast absorption with reliable plasma concentration, delivering pain control within 30-60 minutes and lasting up to 8 hours. ASPADOL 75 ATB is particularly effective in treating postoperative pain, musculoskeletal disorders, neuropathic pain syndromes including diabetic peripheral neuropathy, and chronic conditions such as osteoarthritis. Manufactured under Dr Precision's GMP-compliant standards and WHO-GMP certified processes, ASPADOL 75 ATB adheres to rigorous quality control measures, ensuring uniformity, high bioavailability, and shelf stability. The product is suitable for hospitals, pain clinics, and emergency care centers requiring reliable intermediate-potency analgesics with reduced opioid-related adverse effects. Available in customizable packaging formats, it supports seamless integration into global pharmaceutical markets with comprehensive regulatory documentation for distribution and export. ASPADOL 75 ATB represents a next-generation opioid analgesic option that balances efficacy and safety for enhanced clinical outcomes in pain management protocols.
Key Features
| Features | Description |
|---|---|
| Active Ingredient | Tapentadol Hydrochloride 75 mg |
| Mechanism of Action | Mu-opioid receptor agonist and norepinephrine reuptake inhibitor |
| Indications | Moderate to severe acute and chronic pain, including post-surgical and neuropathic pain |
| Onset of Action | 30 to 60 minutes |
| Duration of Pain Relief | 6 to 8 hours |
| Gastrointestinal Side Effects | Reduced compared to traditional opioids |
| Pharmacokinetic Profile | Fast absorption with predictable plasma levels |
| Manufacturing Standards | Dr Precision label, WHO-GMP certified, GMP compliant |
| Packaging Options | Blister packs, bottles, customizable packaging |
| Suitability | Hospitals, pain clinics, emergency care units |
| Attributes | Description |
|---|---|
| Dosage Form | Oral tablet |
| Strength | 75 mg Tapentadol Hydrochloride |
| Administration Route | Oral |
| Therapeutic Category | Analgesic, opioid analgesic alternative |
| Pharmacological Class | Centrally acting analgesic with dual mechanism |
| Regulatory Status | Schedule II or III substance depending on region |
| Quality Assurance Tests | Dissolution, content uniformity, microbial limits, assay validation |
| Storage Conditions | Store in a cool, dry place away from direct sunlight |
| Shelf Life | As per manufacturer’s stability data |
| Packaging Material | Pharmaceutical-grade blister packs or bottles |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
ASPADOL 75 ATB combines mu-opioid receptor agonism with norepinephrine reuptake inhibition, providing both rapid analgesia and modulation of pain transmission pathways. This dual mechanism not only enhances pain relief efficacy but also reduces common opioid-related gastrointestinal side effects, improving patient tolerance during treatment.
The 75 mg dose is ideal for patients requiring moderate-strength pain control, often during dose titration or when lower strengths do not provide adequate relief. It serves as an intermediary dose for managing moderate to severe acute or chronic pain before moving to higher potency if needed.
Each batch undergoes rigorous quality control including dissolution testing, content uniformity assays, microbial limit checks, and validation of active ingredient potency, all under GMP and WHO-GMP certified manufacturing processes to ensure product safety, efficacy, and stability.
Yes, ASPADOL 75 ATB is effective in treating neuropathic pain such as diabetic peripheral neuropathy due to its norepinephrine reuptake inhibition in addition to opioid receptor activity, providing a broader therapeutic effect on nerve-related pain.
Its reduced incidence of gastrointestinal side effects and lower risk of respiratory depression compared to traditional opioids make ASPADOL 75 ATB more tolerable for long-term therapy, enhancing patient compliance and safety.
Country Of Origin: India
ASPADOL 75 ATB is a prescription-strength tablet containing Tapentadol Hydrochloride 75 mg, used for the effective management of moderate to severe acute and chronic pain. It combines both opioid receptor agonism and norepinephrine reuptake inhibition to deliver rapid and sustained analgesic effects. ASPADOL 75 ATB offers strong pain control with a reduced risk of gastrointestinal side effects compared to traditional opioids, making it an advanced choice in pain management therapy.
This product is manufactured under the Dr Precision label, ensuring GMP-compliant quality and precision formulation standards.
ASPADOL 75 ATB is a pharmaceutical-grade pain relief tablet formulated with 75 mg of Tapentadol Hydrochloride, an innovative centrally acting analgesic with dual mechanisms of action. It works both as a mu-opioid receptor agonist and a norepinephrine reuptake inhibitor (NRI), offering a powerful yet balanced approach to the treatment of moderate to severe pain. This combination provides rapid onset of relief while reducing the intensity of pain transmission and enhancing the patient’s overall comfort.
Tapentadol, the active ingredient in ASPADOL 75 ATB, is considered a next-generation painkiller. It is particularly effective for managing acute post-surgical pain, musculoskeletal pain, neuropathic pain, and pain associated with chronic conditions such as osteoarthritis and diabetic peripheral neuropathy. The 75 mg dosage offers an intermediate level of potency suitable for patients who require more relief than lower doses can provide but may not yet need maximum strength therapy. It is also used during dose titration to determine a patient’s optimal pain control regimen.
Unlike traditional opioids such as morphine or oxycodone, Tapentadol offers comparable analgesic efficacy with a lower incidence of gastrointestinal side effects such as nausea, constipation, and vomiting. This makes ASPADOL 75 ATB more tolerable for long-term use and improves adherence among patients with sensitivity to opioid side effects. Additionally, Tapentadol has a lower binding affinity for the mu-opioid receptor, which results in reduced risk of respiratory depression and sedation when compared to classical opioids.
ASPADOL 75 ATB has a favorable pharmacokinetic profile, with fast absorption and predictable plasma levels. Its onset of action begins within 30 to 60 minutes and provides pain relief for up to 6 to 8 hours depending on the patient’s condition and metabolism. The tablet is formulated for oral use, with or without food, and should be administered at regular intervals as prescribed by a healthcare provider. The 75 mg dose is commonly used in rotation with other strengths to gradually adjust pain therapy based on patient response and tolerance.
BluepillExpress offers ASPADOL 75 ATB as part of its high-quality range of analgesics produced under WHO-GMP certified conditions. The formulation is developed using advanced pharmaceutical technologies that ensure uniformity, bioavailability, and shelf-life stability. The tablets are manufactured using high-purity raw materials, tested rigorously for compliance with international pharmacopoeial standards. Batch-wise quality control includes dissolution testing, content uniformity, microbial limit tests, and assay validation.
As pain management becomes an increasingly critical area of care in orthopedics, oncology, geriatrics, and post-operative recovery, ASPADOL 75 ATB is positioned as a reliable and effective solution. It is suited for hospitals, pain clinics, emergency care units, and outpatient use where short to intermediate pain control is essential. In global markets, Tapentadol is recognized as a Schedule II or III substance (depending on region), and therefore, its production, distribution, and export require appropriate regulatory and licensing compliance.
BluepillExpress supports its third-party manufacturing partners with full technical documentation including product dossiers, certificates of analysis, stability data, and assistance with international registration and licensing. Packaging options are flexible to meet client branding and labeling needs, whether for institutional supply, private marketing, or export into semi-regulated and regulated pharmaceutical markets. ASPADOL 75 ATB can be delivered in blister packs, bottles, or customized packaging formats based on partner requirements.
The demand for advanced opioid alternatives continues to rise due to growing awareness of opioid tolerance, abuse potential, and chronic pain burden. Tapentadol, with its unique dual-action mechanism, offers a safer yet effective therapeutic approach. ASPADOL 75 ATB stands out as a mid-range dosage option that can be flexibly incorporated into multimodal pain management protocols. Its balanced efficacy and safety profile make it a valuable addition to any clinical or commercial pharmaceutical portfolio.
In conclusion, ASPADOL 75 ATB provides effective, fast-acting, and well-tolerated relief for moderate to severe pain. It is an ideal choice for healthcare professionals seeking an advanced alternative to conventional opioids with fewer side effects. Manufactured to the highest quality standards by BluepillExpress, ASPADOL 75 ATB is a dependable and globally viable product for pain relief markets, ensuring both therapeutic value and commercial potential.
Inclusive of all taxes
You Save: 0
Surat , India
Manufacturer, Contractor, Retailer, Brand Owner, Distributor, Exporter, Importer, Wholesaler, Startup
GST- 24abdfb4194j1ze
